Detalhe da pesquisa
1.
Prostate cancer induces C/EBPß expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome.
Prostate
; 79(5): 435-445, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30536410
2.
Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome.
Mod Pathol
; 32(9): 1310-1319, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30980038
3.
Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer.
Biochim Biophys Acta
; 1831(10): 1579-87, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23262399
4.
Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray.
Prostate
; 74(11): 1107-17, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24913716
5.
Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome.
Am J Pathol
; 179(4): 1961-8, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21854754
6.
LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer.
Int J Cancer
; 128(12): 2843-52, 2011 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21128282
7.
Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.
Am J Pathol
; 177(2): 1031-41, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20616342
8.
Inhibitory effects of castration in an orthotopic model of androgen-independent prostate cancer can be mimicked and enhanced by angiogenesis inhibition.
Clin Cancer Res
; 12(24): 7431-6, 2006 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17189416
9.
High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting.
PLoS One
; 11(10): e0164016, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27764093
10.
Morphological and morphometric characterization of direct transdifferentiation of support cells into hair cells in ototoxin-exposed neonatal utricular explants.
Hear Res
; 321: 1-11, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25576788
11.
High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting.
PLoS One
; 10(10): e0140985, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26501565
12.
TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers.
PLoS One
; 9(2): e86824, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24505269
13.
ErbB2 receptor immunoreactivity in prostate cancer: relationship to the androgen receptor, disease severity at diagnosis and disease outcome.
PLoS One
; 9(9): e105063, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25215939
14.
High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.
Eur J Cancer
; 50(10): 1829-1835, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24726733
15.
Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15.
Cancer Res
; 74(13): 3408-17, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24780757
16.
Association between cannabinoid CB1 receptor expression and Akt signalling in prostate cancer.
PLoS One
; 8(6): e65798, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23755281
17.
Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expression.
PLoS One
; 7(10): e47994, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23133535
18.
Tumor indicating normal tissue could be a new source of diagnostic and prognostic markers for prostate cancer.
Expert Opin Med Diagn
; 5(1): 37-47, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23484475
19.
Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer.
PLoS One
; 5(12): e15205, 2010 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21203460
20.
Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4.
PLoS One
; 5(8): e12275, 2010 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-20808855